Belguendouz Bendahmane

Adjuvant Trastuzumab in HER2-Positive Breast Cancer

Dennis J. Slamon, W. Eiermann, Nicholas J. Robert et al. · New England Journal of Medicine · 2011 · 2.8K citations · Full text

Medicine, Oncology, Pharmacology +17

Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial

Jaafar Bennouna, Javier Sastre, Dirk Arnold et al. · The Lancet Oncology · 2012 · 1.2K citations · Full text

Medicine, Oncology, Pharmacology +10

Adjuvant Chemotherapy With Sequential or Concurrent Anthracycline and Docetaxel: Breast International Group 02 98 Randomized Trial

Prudence A. Francis, John Crown, Angelo Di Leo et al. · JNCI Journal of the National Cancer Institute · 2008 · 149 citations · Full text

Medicine, Oncology, Pharmacology +13

Bevacizumab (BEV) plus chemotherapy (CT) continued beyond first progression in patients with metastatic colorectal cancer (mCRC) previously treated with BEV plus CT: Results of a randomized phase III intergroup study (TML study).

Dirk Arnold, Thierry André, Jaafar Bennouna et al. · Journal of Clinical Oncology · 2012 · 70 citations

Medicine, Oncology, Pharmacology +10

Phase II trial of fludarabine monophosphate in patients with mantle-cell lymphomas.

Didier Decaudin, J. Bosq, G. Tertian et al. · Journal of Clinical Oncology · 1998 · 67 citations

Medicine, Hematology, Pharmacotherapy +17